Algert Global LLC Purchases 58,267 Shares of Aspen Aerogels, Inc. $ASPN

Algert Global LLC increased its holdings in Aspen Aerogels, Inc. (NYSE:ASPN) by 13.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 498,738 shares of the construction company’s stock after purchasing an additional 58,267 shares during the quarter. Algert Global LLC’s holdings in Aspen Aerogels were worth $3,187,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. raised its position in Aspen Aerogels by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 4,373,159 shares of the construction company’s stock valued at $27,944,000 after purchasing an additional 12,913 shares during the last quarter. Oaktop Capital Management II L.P. raised its holdings in shares of Aspen Aerogels by 5.6% during the fourth quarter. Oaktop Capital Management II L.P. now owns 3,740,525 shares of the construction company’s stock valued at $44,437,000 after acquiring an additional 200,000 shares in the last quarter. Needham Investment Management LLC lifted its stake in Aspen Aerogels by 5.2% in the fourth quarter. Needham Investment Management LLC now owns 2,389,700 shares of the construction company’s stock worth $28,390,000 after acquiring an additional 117,500 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Aspen Aerogels by 25.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company’s stock valued at $23,983,000 after acquiring an additional 409,862 shares in the last quarter. Finally, Millennium Management LLC increased its position in Aspen Aerogels by 4,757.8% during the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company’s stock valued at $19,270,000 after purchasing an additional 1,588,632 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Activity at Aspen Aerogels

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the business’s stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the transaction, the chief accounting officer owned 19,879 shares in the company, valued at $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 3.40% of the company’s stock.

Aspen Aerogels Trading Down 4.0%

Aspen Aerogels stock opened at $6.8230 on Wednesday. Aspen Aerogels, Inc. has a 12 month low of $4.16 and a 12 month high of $33.15. The company has a market capitalization of $561.94 million, a price-to-earnings ratio of -1.79 and a beta of 2.73. The business’s fifty day simple moving average is $6.89 and its two-hundred day simple moving average is $6.85. The company has a current ratio of 3.98, a quick ratio of 3.31 and a debt-to-equity ratio of 0.34.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.08. The business had revenue of $78.02 million during the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. Aspen Aerogels’s revenue was down 33.8% compared to the same quarter last year. During the same period last year, the business earned $0.21 EPS. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. As a group, equities analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Analyst Ratings Changes

ASPN has been the topic of a number of research reports. Barclays lowered shares of Aspen Aerogels from an “equal weight” rating to an “underweight” rating and lifted their target price for the company from $7.00 to $16.00 in a research note on Monday, August 11th. Canaccord Genuity Group dropped their price target on Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Finally, Oppenheimer downgraded Aspen Aerogels from an “outperform” rating to a “market perform” rating in a report on Thursday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Aspen Aerogels has an average rating of “Moderate Buy” and a consensus target price of $19.50.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.